1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors

被引:30
作者
Mulvihill, Mark J. [1 ]
Ji, Qun-Sheng [1 ]
Werner, Doug [1 ]
Beck, Patricia [1 ]
Cesario, Cara [1 ]
Cooke, Andrew [1 ]
Cox, Matthew [1 ]
Crew, Andrew [1 ]
Dong, Hanqing [1 ]
Feng, Lixin [1 ]
Foreman, K. W. [1 ]
Mak, Gilda [1 ]
Nigro, Anthony [1 ]
O'Connor, Matthew [1 ]
Saroglou, Lydia [1 ]
Stolz, Kathryn M. [1 ]
Sujka, Izabela [1 ]
Volk, Brian [1 ]
Weng, Qinghua [1 ]
Wilkes, Robin [1 ]
机构
[1] OSI Pharmaceut Inc, Farmingdale, NY 11735 USA
关键词
IGF-IR; IR; tyrosine kinase inhibitors; oncology; imidazopyrazines; imidazo[1,5-a]pyrazines; insulin-like growth-factor-I; receptor; insulin receptor;
D O I
10.1016/j.bmcl.2006.11.016
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 8-amino-1,3-disubstituted-imidazo[1,5-a]pyrazines was designed and synthesized as IGF-IR inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1091 / 1097
页数:7
相关论文
共 52 条
[31]   Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines:: Potent inhibitors of the tyrosine kinase c-Src [J].
Missbach, M ;
Altmann, E ;
Widler, L ;
Susa, M ;
Buchdunger, E ;
Mett, H ;
Meyer, T ;
Green, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) :945-949
[32]   Protein kinase inhibitors: Insights into drug design from structure [J].
Noble, MEM ;
Endicott, JA ;
Johnson, LN .
SCIENCE, 2004, 303 (5665) :1800-1805
[33]   First metallation of iodo diazines.: Iodo and nitrogen directed metallations.: Diazines XXII. [J].
Plé, N ;
Turck, A ;
Heynderickx, A ;
Quéguiner, G .
TETRAHEDRON, 1998, 54 (33) :9701-9710
[34]   Insulin-like growth factors and neoplasia [J].
Pollak, MN ;
Schernhammer, ES ;
Hankinson, SE .
NATURE REVIEWS CANCER, 2004, 4 (07) :505-518
[35]   DOMINANT-NEGATIVE INHIBITION OF TUMORIGENESIS IN-VIVO BY HUMAN INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR MUTANT [J].
PRAGER, D ;
LI, HL ;
ASA, S ;
MELMED, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2181-2185
[36]  
Qing RQ, 1996, PEDIATR RES, V39, P160
[37]   Insulin-like growth factor expression in human cancer cell lines [J].
Quinn, KA ;
Treston, AM ;
Unsworth, EJ ;
Miller, MJ ;
Vos, M ;
Grimley, C ;
Battey, J ;
Mulshine, JL ;
Cuttitta, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11477-11483
[38]   A fast flexible docking method using an incremental construction algorithm [J].
Rarey, M ;
Kramer, B ;
Lengauer, T ;
Klebe, G .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (03) :470-489
[39]  
RESNICOFF M, 1994, CANCER RES, V54, P4848
[40]   Opportunities and challenges in the development of kinase inhibitor therapy for cancer [J].
Sawyers, CL .
GENES & DEVELOPMENT, 2003, 17 (24) :2998-3010